Docetaxel
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01248 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | female breast carcinoma | KG + DL |
| 2 | Ewing sarcoma | KG + DL |
| 3 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 4 | small cell lung carcinoma | KG + DL |
| 5 | primary pulmonary lymphoma | KG + DL |
| 6 | botryoid-type embryonal rhabdomyosarcoma of the vagina | KG + DL |
| 7 | pulmonary blastoma | KG + DL |
| 8 | rhabdomyosarcoma (disease) | KG + DL |
| 9 | embryonal extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 10 | parameningeal embryonal rhabdomyosarcoma | KG + DL |
| 11 | hereditary breast ovarian cancer syndrome | KG + DL |
| 12 | prostate embryonal rhabdomyosarcoma | KG + DL |
| 13 | extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 14 | liver sarcoma | KG + DL |
| 15 | uterine corpus sarcoma | KG + DL |
| 16 | orbit sarcoma | KG + DL |
| 17 | synovial chondromatosis | KG + DL |
| 18 | giant cell tumor of soft tissue | KG + DL |
| 19 | sarcoma, avian | KG + DL |
| 20 | lung mixed small cell and squamous cell carcinoma | KG + DL |
| 21 | ganglioneuroblastoma (disease) | KG + DL |
| 22 | neuroblastoma | KG + DL |
| 23 | retroperitoneal neoplasm | KG + DL |
| 24 | neutrophil immunodeficiency syndrome | KG + DL |
| 25 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 26 | 2q33.1 microdeletion syndrome | KG + DL |
| 27 | bone sarcoma | KG + DL |
| 28 | hormone-resistant breast carcinoma | KG + DL |
| 29 | estrogen-receptor positive breast cancer | KG + DL |
| 30 | Ehrlich tumor carcinoma | KG + DL |
| 31 | estrogen-receptor negative breast cancer | KG + DL |
| 32 | nipple carcinoma | KG + DL |
| 33 | CMM7 | KG + DL |
| 34 | extraskeletal Ewing sarcoma/peripheral primitive neuroectodermal tumor | KG + DL |
| 35 | osteoclastic giant cell tumor of pancreas | KG + DL |
| 36 | solid pseudopapillary carcinoma of pancreas | KG + DL |
| 37 | pediatric leptomeningeal melanoma | KG + DL |
| 38 | epithelioid cell uveal melanoma | KG + DL |
| 39 | skeletal muscle neoplasm | KG + DL |
| 40 | Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone | KG + DL |
| 41 | bilateral breast carcinoma | KG + DL |
| 42 | pancreatic carcinoma with mixed differentiation | KG + DL |
| 43 | myeloid leukemia | KG + DL |
| 44 | pancreatic adenocarcinoma | KG + DL |
| 45 | mixed ductal-endocrine carcinoma of pancreas | KG + DL |
| 46 | melanoma | KG + DL |
| 47 | breast carcinoma by gene expression profile | KG + DL |
| 48 | pancreatic intraductal papillary-mucinous carcinoma | KG + DL |
| 49 | pancreatic signet ring cell adenocarcinoma | KG + DL |
| 50 | undifferentiated pancreatic carcinoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.